Cutera Reports Record Third Quarter 2016 Results

  • Revenue increased 31% year-over-year to $30.3 million
  • Revenue achievement represents record third quarter, and second highest quarter in Company’s history
  • Ninth consecutive quarter of double-digit revenue growth
  • Achieved GAAP profitability and significant operating cash flow

BRISBANE, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Cutera, Inc. (NASDAQ:CUTR) (“Cutera” or the “Company”), a leading provider of laser and energy-based aesthetic systems for practitioners worldwide, today reported financial results for the third quarter ended September 30, 2016.

Key operating highlights and financial performance for the third quarter of 2016, when compared to the third quarter of 2015, were as follows:

  • Revenue increased 31% to $30.3 million, due to strong growth in Product revenue in North America and Rest of World of 28% and 52%, respectively.
  • Gross Margin increased to 59%, primarily due to leverage from revenue growth.
  • GAAP Net Income increased $2.6 million from a net loss of $1.0 million a year ago, to a $1.6 million profit. Earnings per diluted share were $0.12, compared to a loss per share of $0.07.
  • Cash generated by operations was $1.6 million.
  • Repurchased 176,000 shares of common stock for $1.9 million from the $10.0 million board-approved stock repurchase program. Remaining balance on the authorized $10.0 million program was $5.1 million.
  • Cash, cash equivalents and marketable investments were $46.4 million, and no debt.

Ron Santilli, Interim Chief Executive Officer and Chief Financial Officer of Cutera, stated, “We are pleased with our ninth consecutive quarter of double-digit revenue growth and the improved financial performance. We are particularly excited about our return to profitability and cash generation, which illustrates the leverage in our business model. Our financial performance in the third quarter, and overall trajectory, has the Company on track with our previously stated goals of strong revenue growth and GAAP profitability for the full-year of 2016.”

In the third quarter of 2016, the Company’s Product revenue grew substantially in the North American and Rest-of-World regions, as well as across all of the major product platforms, including the newly released products as well as our legacy products.

“We continue to expand the functionality of our enlighten platform. In October 2016, we expanded its utility into skin revitalization by adding PicoGenesisTM and we just recently received a 510(k) clearance from the FDA for a third wavelength, “a true red” 670nm, for benign pigmented lesions. The 670nm wavelength will allow for greater clinical capabilities to our customers. We are in the process of finalizing our launch plans for a three wave length enlighten III platform, which we expect will start shipping commercially towards the end of the fourth quarter of 2016. We believe this new product will be the best-in-class, three wavelength laser in the market that will allow our customers the ability to remove all tattoo ink colors and provide PicoGenesis skin revitalization — with improved efficacy and faster treatment than any other system in the market,” said Mr. Santilli.

Mr. Santilli concluded, “We remain committed to advancing our technologies and to providing our customers with an attractive path for upgrading their current systems to the new capabilities. We are well positioned to achieve continued year-over-year profitable growth in the fourth quarter as we continue to execute on the various initiatives for expanding our market share in the growing aesthetic medical equipment market.”

Conference Call

The conference call to discuss these results is scheduled to begin at 2:00 p.m. PST (5:00 p.m. EST) on November 7, 2016. Participating in the call will be Ron Santilli, Interim Chief Executive Officer and Chief Financial Officer. The call will be broadcast live over the internet hosted at the Investor Relations section of Cutera's website at: and will be archived online within one hour of its completion through 8:59 p.m. PST (11:59 p.m. EST) on November 21, 2016. In addition, you may call 1-877-705-6003 if you wish to participate on the live call.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's plans to introduce and commercialize new products, ability to increase revenue, reduce expenses, improve financial results, grow the Company’s market share, realize benefits from additional investment, achieve financial guidance, expand market penetration, generate cash from operations, and statements regarding long-term prospects and opportunities in the laser and other energy-based equipment aesthetic market, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include those related to the Company’s efforts to improve sales productivity, hire and retain qualified sales representatives, improve revenue growth, gross margins and profitability through leveraging operating expenses; the Company’s ability to successfully develop and launch new products and applications and market them to both its installed base and new customers; unforeseen events and circumstances relating to the Company’s operations; government regulatory actions; and those other factors described in the section entitled, “Risk Factors” in its most recent Form 10-Q as filed with the Securities and Exchange Commission on November 7, 2016. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. Cutera's financial performance for the third quarter ended September 30, 2016, as discussed in this release, is preliminary and unaudited, and subject to adjustment.

(in thousands, except per share data)
Three Months Ended
September 30, September 30,
2016 2015
Net revenue $ 30,281 $ 23,085
Cost of revenue 12,538 9,594
Gross profit 17,743 13,491
Gross margin % 59% 58%
Operating expenses:
Sales and marketing 10,574 8,790
Research and development 2,914 2,748
General and administrative 2,716 2,937
Total operating expenses 16,204 14,475
Income (Loss) from operations 1,539 (984)
Interest and other income, net 166 84
Income (Loss) before income taxes 1,705 (900)
Provision for income taxes 61 57
Net income (loss) $ 1,644 $ (957)
Net income (loss) per share:
Basic $ 0.12 $ (0.07)
Diluted $ 0.12 $ (0.07)
Weighted-average number of shares used in per share calculations:
Basic and diluted 13,163 13,827
Diluted 13,544 13,827

(in thousands)
September 30, June 30, September 30,
2016 2016 2015
Current assets:
Cash and cash equivalents $11,275 $7,420 $10,055
Marketable investments 35,108 35,902 37,689
Cash, cash equivalents and marketable investments 46,383 43,322 47,744
Accounts receivable, net 11,680 11,181 9,013
Inventories 16,478 14,702 13,479
Deferred tax asset - - 69
Other current assets and prepaid expenses 2,507 2,619 1,977
Total current assets 77,048 71,824 72,282
Property and equipment, net 1,720 1,577 1,386
Deferred tax asset, net of current portion 410 401 291
Intangibles, net 16 44 227
Goodwill 1,339 1,339 1,339
Other long-term assets 444 448 392
Total assets $80,977 $75,633 $75,917
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable $3,283 $2,752 $2,659
Accrued liabilities 14,786 13,201 12,234
Deferred revenue 8,312 8,919 8,470
Total current liabilities 26,381 24,872 23,363
Deferred revenue, net of current portion 1,426 1,685 2,495
Income tax liability 164 157 187
Other long-term liabilities 597 587 538
Total liabilities 28,568 27,301 26,583
Stockholders' equity 52,409 48,332 49,334
Total liabilities and stockholders' equity $80,977 $75,633 $75,917

(in thousands)
Three Months Ended
September 30, September 30,
2016 2015
Cash flows from operating activities:
Net income (loss)$ 1,644 $ (957)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation 570 1,044
Depreciation and amortization 249 290
Other 18 (32)
Changes in assets and liabilities:
Accounts receivable (525) (94)
Inventories (1,776) 42
Accounts payable 531 (938)
Accrued liabilities 1,659 1,230
Deferred revenue (866) (801)
Other 99 (398)
Net cash provided by (used in) operating activities 1,603 (614)
Cash flows from investing activities:
Acquisition of property, equipment and software (174) (25)
Disposal of property and equipment 11 -
Net change in marketable investments 711 16,941
Net cash provided by investing activities 548 16,916
Cash flows from financing activities:
Repurchases of common stock (2,008) (18,872)
Proceeds from exercise of stock options and employee stock purchase plan 3,803 1,046
Payments on capital lease obligations (91) (48)
Net cash provided by (used in) financing activities 1,704 (17,874)
Net increase (decrease) in cash and cash equivalents 3,855 (1,572)
Cash and cash equivalents at beginning of period 7,420 11,627
Cash and cash equivalents at end of period$ 11,275 $ 10,055

(in thousands, except percentage data)
Three Months Ended % Change
Q3 Q3 Q3 '16 Vs
2016 2015 Q3 '15
Revenue By Geography:
United States $ 15,356 $ 13,206 +16%
International 14,925 9,879 +51%
$ 30,281 $ 23,085 +31%
International as a percentage of total revenue 49% 43%
Revenue By Product Category:
-North America $ 13,896 $ 10,830 +28%
-Rest of the World 9,983 6,562 +52%
Total Products 23,879 17,392 +37%
Service 4,788 4,288 +12%
Hand Piece Refills 602 671 -10%
Skincare 1,012 734 +38%
$ 30,281 $ 23,085 +31%
Three Months Ended
Q3 Q3
2016 2015
Pre-tax Stock-Based Compensation Expense:
Cost of revenue $ 73 $ 112
Sales and marketing 239 311
Research and development 131 148
General and administrative 127 473
$ 570 $ 1,044

CONTACTS: Cutera, Inc. Ron Santilli Interim Chief Executive Officer and Chief Financial Officer 415-657-5500 Investor Relations John Mills ICR, Inc. 646-277-1254

Source:Cutera, Inc